Author:
Buhse Susanne,Mühlhauser Ingrid
Publisher
Springer International Publishing
Reference63 articles.
1. Chamberlain JJ, Herman WH, Leal S, et al. Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2017;166:572–8.
2. Boussageon R, Gueyffier F, Cornu C. Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence? Diabetes Metab. 2014;40:169–75.
3. Buhse S, Mühlhauser I, Lenz M. The ‘old’ anti-diabetic agents: a systematic inventory. In: Stettler C, Christ E, Diem P (Hrsg.), editors. Novelties in diabetes. Endocr Dev. Basel: Karger. 2015;31:28–42.
4. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. NEJM. 2008;358:2545–59.
5. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEJM. 2009;360:129–39.